Clinical trialNCT05961592RecruitingPhase 1Interventional

R-2487 in Patients With Rheumatoid Arthritis

SponsorRise Therapeutics LLCEnrollment73Arthritis, Rheumatoid

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-2487) in patients with Rheumatoid Arthritis. Patients will take an oral dosage of probiotic (R-2487) and physicians will assess and measure their Rheumatoid Arthritis. Blood and fecal evaluations of inflammation and assessment of probiotic (R-2487) on fecal level will also be measured.

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California, San Diego
San Diego, California, United States
Monica Guma, M.D.
Recruiting
St.Jude Clinical Research
Doral, Florida, United States
Gustavo Torres, MD
Recruiting
Ap Medical Research
Miami, Florida, United States
Idania Fernandez, MD
Recruiting
Edward Jenner Research
Plantation, Florida, United States
Steven Gelbard, MD
Recruiting
Altoona Center for Research
Duncansville, Pennsylvania, United States
Alan Kivitz, MD
Recruiting
Prolato Clinical Research Center
Houston, Texas, United States
Michelle Eisenberg, M.D.
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

R-2487 DP

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Oct 2023
Primary completion: 30 Nov 2026
Completion: 31 Dec 2026
Last update posted: 12 Jun 2026
Registered enrollment: 73
Registry id: NCT05961592

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.